Indication: Acute Coronary Syndrome (ACS)
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome
Sub-indication: Acute Coronary Syndrome (ACS)
Study Type: Drug Study
Principal Investigator: Vipul Panchal, M.D.Norton Heart & Vascular Institute
Sponsor: Sponsor: CSL Behring LLC
Learn more at ClinicalTrials.gov
Email for more information: CVResearch@nortonhealthcare.org